London, UK (PRWEB) December 20, 2012

Enteric diseases are considered to be the second reason of the infectious disease mortality across the globe. 95% of cases of enteric infections are discovered in developing regions given poor sanitary conditions there. Rising health awareness, development of new diagnostic and treatment products and technological advancements are driving the enteric disease market growth. Abbott, BioMerieux, Beckman Coulter/Danaher, Ortho-Clinical Diagnostics, Siemens, Roche, Tosoh and Wallac are among the prominent market participants.

The enteric vaccine segment is the most perspective one. Development of new vaccines is rather problematic given the existence of a slew of enteric pathogens causing various diseases. Nevertheless, medical companies constantly work on new vaccines. For instance, one of recently launched vaccine development programs is aimed at the elaboration of the vaccine against the most common bacteria provoking diarrhea enterotoxigenic Escherichia coli (ETEC) and Shigella.

New market research report Global Enteric Disease Market: Innovative Technologies and Emerging Business Opportunities prepared by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Enteric Disease Market: Innovative Technologies and Emerging Business Opportunities

Published: December, 2012

Pages: 389

Price: US$ 9,800.00

http://marketpublishers.com/report/life_sciences/diagnostics-diseases/global-enteric-disease-market-innovative-technologies-n-emerging-business-opportunities.html

The report offers a deep insight into the global Enteric Disease Market. It presents detailed analysis of the market in the USA, France, Germany, Italy, Spain, the UK and Japan, including information on the market size and factors driving the market growth. The research provides comprehensive assessment of the market competition; indicates key suppliers and reveals their market shares and sales dynamics. The review of emerging technologies and their applications as well as examination of leading analyzers is also available in the study. The report discusses major infectious disease tests, describes alternative market penetration strategies and outlines potential market entry barriers and risks. In addition, future prospects for the worldwide enteric disease market are uncovered in the study.

Infectious disease tests mentioned in the report include: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.

Reasons to Buy: